Although immunoapheresis removing autoantibodies against the second extracellular domain of ␤ 1 -adrenergic receptors (ARs) improves cardiac function in patients with cardiomyopathy, the underlying mechanisms have not been defined. We examined the role of autoimmunity against the domain in the development of cardiac dysfunction in vivo. Japanese white rabbits were immunized with a synthetic peptide corresponding to the second extracellular loop of ␤ 1 -AR once a month with (␤ϩbiso rabbits, nϭ10) or without (␤ rabbits, nϭ13) bisoprolol treatment (2 mg/kg per day). Control rabbits received vehicle without bisoprolol treatment (nϭ13). Autoantibodies of IgG isotype against the domain were persistently detected in ␤ and ␤ϩbiso rabbits. Purified IgG from sera of ␤ and ␤ϩbiso rabbits increased cAMP production in a rabbit cardiac membrane preparation, which was blocked by bisoprolol. At 3 months, ␤-AR uncoupling with increased G protein-coupled receptor kinase 5 (GRK5) expression was found in ␤ rabbits. At 6 months, left ventricular hypertrophy was noted with hemodynamic derangements in ␤ rabbits. This was accompanied by decreased ␤ 1 -AR density and increased inhibitory G protein and GRK5 expression, which were related to marked decrease in membrane cAMP production. These changes in ␤ rabbits at 6 months were prevented in ␤ϩbiso rabbits. There was no difference in the plasma norepinephrine concentration in the 3 groups over the observation period. Thus, autoimmunity against the second extracellular loop of ␤ 1 -ARs induced profound ␤-AR desensitization and myocardial hypertrophy in vivo, associated with cardiac dysfunction. Sustained sympathomimetic-like actions of autoantibodies against the domain may be partly responsible for these changes. (Circ Res. 2001;88:578-586.) 
C ertain forms of acquired cardiomyopathy are associated with autoimmunity as well as virus infection. 1 Autoantibodies against the second extracellular domain of ␤ 1adrenergic receptors (ARs) are prevalent in patients with cardiomyopathy. [2] [3] [4] Immunoapheresis removing these autoantibodies ameliorates their symptoms and hemodynamic abnormalities. 5 This suggests that autoimmunity against the domain plays a role in the development of cardiac dysfunction in cardiomyopathy. However, the underlying mechanisms have not been defined.
Previous studies have shown that autoantibodies against the second extracellular domain of ␤ 1 -ARs exert sustained intrinsic sympathomimetic-like actions on cardiomyocytes in vitro. 2 Because chronic stimulation of ␤-ARs gives rise to alterations in cardiac ␤-adrenergic signaling, 6 -8 myocardial hypertrophy, 7, 9 or damage, 10 we speculated that autoimmunity might be responsible for such changes, leading to the development of cardiomyopathy and cardiac dysfunction. Actually, autoantibodies against the domain are found in patients with hypertrophic cardiomyopathy as well as dilated cardiomyopathy. 3, 4 Although it is clear that ␤-adrenergic signaling is altered in cardiomyopathy, [11] [12] [13] relations to autoimmunity are not completely understood in vivo. Especially, G protein-coupled receptor kinases (GRKs) are extremely important in modulating myocardial adrenergic signaling and cardiac function. 8, 13, 14 Nevertheless, relationships between autoimmunity and GRKs have not been previously reported.
Beneficial effects of ␤ blockers on cardiac function have been confirmed in patients with cardiomyopathy. [15] [16] [17] ␤ blockers might improve cardiac performance in patients with autoantibodies against the domain by preventing autoimmune-mediated myocardial damage. We sought to clarify the role played by autoimmunity against the second extracellular domain of ␤ 1 -ARs in the development of cardiac dysfunction in vivo, by immunizing rabbits with a peptide corresponding to the domain, together with treatment by bisoprolol, a selective ␤ 1 antagonist.
Materials and Methods
Immunization Experiments were performed in 36 male Japanese white rabbits, which were 10 weeks old (1.80 to 2.20 kg). The experimental protocol was approved by our Institutional Review Board. A synthetic peptide corresponding to the second extracellular loop of rabbit ␤ 1 -AR (residues 197 to 222; HWWRAESDEARRCYNDP-KCCDFVTNR) was produced by Peptide Institute, Inc. Twenty-six rabbits were randomly divided into 2 groups, and they were given distilled water throughout the observation period. Thirteen rabbits were immunized by subcutaneous injection of the peptide (1 mg) dissolved in 1 mL of saline conjugated with 0.5 mL of complete and incomplete Freund's adjuvant once a month (␤ rabbits). Thirteen control rabbits received saline containing adjuvant in the same manner. Ten additional rabbits that were immunized with peptide in the same manner were given oral bisoprolol (2 mg/kg per day) dissolved in distilled water (␤ϩbiso rabbits). Three months after starting immunization, 5 rabbits in each group were euthanized (3M rabbits). The remaining rabbits were immunized over 6 months (6M rabbits). The mean plasma concentration of bisoprolol at 6 hours after oral administration in ␤ϩbiso rabbits was 9.1 ng/mL (2.4ϫ10 Ϫ8 mol/L), which corresponds approximately to the therapeutic plasma level. 18 ELISA Peptide (50 L; 50 g/mL in 0.1 mol/L Na 2 CO 3 ) was used to coat individual wells of a 96-well microtiter plate. The wells were then saturated with PBS supplemented with 3% skim milk, 0.1% Tween-20, and 0.01% merthiolate. Rabbit sera (50 L) diluted 1:200 were added to the coated plates and incubated overnight at 4°C. After 3 washes with PBS, an affinity-purified biotinylated goat anti-rabbit IgG antibody solution, diluted 1:1000 in merthiolate, was allowed to react for 1 hour at room temperature. After 3 washes, the bound biotinylated antibodies were detected using streptavidin-peroxidase (1 L/mL), H 2 O 2 (2.5 mmol/L) and 2,2Ј-azino-di-(ethylbenzthiazoline) sulfonic acid (2 mmol/L). After 30 minutes, the optical densities at 492 nm were determined using an ELISA reader (Sanko Junyaku Co).
Ultrasonic Echocardiography
Echocardiography was performed with the rabbit under anesthesia using 3 mg/kg thiopental sodium (Tanabe Seiyaku Co). The parasternal long-axis views were obtained using a 7.5-MHz transducer connected to a Hewlett-Packard Sonos 500 ultrasonic echocardiographic system (model 77010CF), with the rabbit placed in the lateral decubitus position.
Hemodynamic Measurements
At the end of each observation period, hemodynamic measurements were performed in the open-chest condition under anesthesia with chloral hydrate as described previously, 19 and finally, the hearts were rapidly removed.
Figure 1.
Antibody detection and functional assay. A, ELISA using a synthetic peptide corresponding to the second extracellular loop of ␤ 1 -AR with sera from rabbits. Antibody detection was performed in the same assay at the same time. Optical densities were persistently higher in ␤ and ␤ϩbiso rabbits than in control rabbits over the observation period (PϽ0.001 in the 3 groups of 3M rabbits, PϽ0.0001 in the 3 groups of 6M rabbits, repeated-measures ANOVA). B, Effects of purified IgG (100 g/mL) from rabbits on cAMP production in rabbit cardiac membrane preparations. IgG from ␤ and ␤ϩbiso rabbits increased cAMP production in the absence of either isoproterenol or bisoprolol. *PϽ0.05 vs PBS and IgG from control rabbits in each assay condition (Bonferroni post hoc test). C, Concentration-response relationships on cAMP production in rabbit cardiac membrane preparations for purified IgG from rabbits, isoproterenol, and effects of bisoprolol on these parameters. Concentration-response curves of the IgG in the presence or absence of bisoprolol (C-1) and curves of isoproterenol in the presence of IgG or bisoprolol (C-2) are shown. Solid lines indicate curves in the absence of bisoprolol. Dashed lines indicate curves in the presence of bisoprolol. IgG from ␤ and ␤ϩbiso rabbits acted as partial agonists, whereas bisoprolol acted as an inverse agonist to reverse the actions of IgG and to inhibit those of isoproterenol. Concentrationresponse data are expressed as percentages of net cAMP production stimulated by 10 Ϫ4 mol/L isoproterenol in the absence of either IgG or bisoprolol. All data are meanϮSEM for each group.
Histological Analysis
Excised hearts were fixed in 10% formalin and embedded in paraffin, and both transverse and cross sections (3 m thickness) were obtained. Sections were stained with hematoxylin and eosin and were subjected to light microscopic examinations. Planimetry was performed macroscopically on cross sections of the hearts to evaluate left ventricular (LV) muscle mass and cavity area and microscopically on 100 cross-sectioned myocytes to determine cross-sectional area per myocyte, using NIH Image.
␤-AR Binding Studies
Membrane fractions were prepared using the LV myocardium as described previously. 19 The densities of myocardial ␤-ARs were determined by a ligand binding assay with [ 125 I]iodocyanopindolol (ICYP) (Amersham Biotech) using membrane samples as previously described. 19 Competition binding experiments were performed in duplicate by incubating 50 pmol/L ICYP with (Ϫ)isoproterenol using 16 different concentrations ranging from 10 Ϫ10 to 10 Ϫ3 mol/L. Nonspecific binding was determined using 1 mol/L (Ϫ)propranolol. The ratio of high-to low-affinity binding sites was determined using nonlinear regression analysis with Prism (GraphPad Software, Inc). Receptor-G protein coupling was assessed using 30 mol/L 5Ј-guanylylimidodiphosphate (Gpp[NH]p). The ␤ 1 /␤ 2 subpopulations were determined by competitive binding experiments, which were performed in duplicate by incubating 50 pmol/L ICYP with CGP27012A (Novartis Pharma), a selective ␤ 1 antagonist using 16 different concentrations ranging from 10 Ϫ10 to 10 Ϫ3 mol/L. The percentage of ␤ 1 -ARs was calculated from the high-affinity binding subpopulation.
cAMP Measurements cAMP production was determined using cardiac membrane preparations under basal conditions and after addition of 10 Ϫ5 mol/L isoproterenolϩ10 Ϫ5 mol/L GTP or of 10 Ϫ5 mol/L Gpp(NH)p, as previously described. 19 Concentration-response relationships for isoproterenol were examined at concentrations ranging from 10 Ϫ7 to 10 Ϫ4 mol/L.
Immunoblotting
Immunodetection of stimulatory (Gs) and inhibitory (Gi) G-protein levels in the membrane fraction, as well as of GRK2 and GRK5 protein levels in both the membrane and cytosolic fractions, was performed using standard SDS-PAGE and immunoblotting techniques, as previously described. 20 Protein from each fraction (50 g) was electrophoresed and then immunoblotted. Fixed samples were included on each gel as standard for quantification of the densities of each blot. Antisera against Gs␣ (Upstate Biotechnology, Inc) and Gi␣, GRK2, and GRK5 (Santa Cruz Biotechnology) were used as primary antibodies, and horseradish peroxidase-linked anti-rabbit IgG (Boehringer Mannheim) was used as a secondary antibody to detect individual protein levels. The densities of each blot were quantified by densitometric scanning and standardized by defining the mean density of membrane fraction from control rabbits at 6 months as 1.0 densitometric unit. The specificities of antibody binding for each antigen were confirmed by neutralization assays using blocking peptides.
Functional Assay With Purified IgG From Sera of Rabbits
After hemodynamic measurements, IgG fractions were isolated from sera of rabbits with an Affi-Gel Protein A Monoclonal Antibody Purification System II Kit (Bio-Rad Laboratories) according to the protocol and desalted over a Bio-Gel P-6DG desalting gel (Bio-Rad Laboratories) to be eluted with PBS (pH 7.4). A cardiac membrane preparation from a control rabbit was incubated in the presence or absence of bisoprolol with purified IgG or with PBS (30°C, 30 minutes), followed by incubation in the presence of 10 Ϫ5 mol/L GTP with isoproterenol or with buffer alone (30°C, 10 minutes) to determine cAMP production.
Statistics
Data are expressed as meanϮSEM. Comparisons between 3 groups were performed by 1-way ANOVA accompanied by a Bonferroni post hoc test when appropriate. Changes in optical densities on ELISA and isoproterenol concentration-dependent data on cAMP production in cardiac membrane preparations from 3 groups were analyzed using a repeated-measures ANOVA, whereas differences in mean values between the groups at a specific dose were determined by 1-way ANOVA. Statistical significance was defined as PϽ0.05.
Results
IgG isotype autoantibodies against the second extracellular loop of ␤ 1 -ARs were persistently detected by ELISA, as early as 1 month after starting immunization, in both ␤ and ␤ϩbiso rabbits, but not in the control rabbits ( Figure 1A ). Purified IgG (100 g/mL) from ␤ and ␤ϩbiso rabbits increased cAMP production in cardiac membrane preparations in the absence of either bisoprolol (10 Ϫ7 mol/L) or isoproterenol (10 Ϫ6 mol/L), whereas IgG from control rabbits did not have a significant effect. In contrast, isoproterenol-stimulated cAMP production was partly inhibited by the IgG from ␤ or ␤ϩbiso rabbits. In the presence of bisoprolol, the stimulatory effects of the IgG from ␤ and ␤ϩbiso rabbits, as well as those of isoproterenol, were abolished ( Figure 1B) . Moreover, we examined the concentration-response relationships on cAMP production for the purified IgG and isoproterenol and the effects of bisoprolol on these parameters. IgG from ␤ and ␤ϩbiso rabbits increased cAMP production in a concentration-dependent manner, whereas the maximum responses were lower than those of isoproterenol ( Figure 1C-1 ). On the other hand, IgG from ␤ and ␤ϩbiso rabbits inhibited isoproterenol-stimulated cAMP production in a concentration-dependent manner ( Figure 1C-2 ). These results demonstrate that autoantibodies from ␤ and ␤ϩbiso rabbits act as partial agonists for ␤ 1 -ARs, competing with the full agonist isoproterenol. In the presence of bisoprolol, basal cAMP production in the absence of either the IgG or isoproterenol was lower than that in the absence of bisoprolol ( Figures 1C-1 and 1C-2), showing that bisoprolol acts as an inverse agonist. 21 Concentration-response curves in the pres- ence of bisoprolol revealed that the stimulatory effects of IgG from ␤ and ␤ϩbiso rabbits were reversed ( Figure 1C-1) , whereas the effects of isoproterenol were partially blocked by bisoprolol ( Figure 1C -2).
Data on cardiac function are summarized in Table 1 . At 3 months, there was no difference in any of the parameters measured among the 3 groups. At 6 months, thickening of both the interventricular septum and the posterior wall was noted with a decrease in the LV end-diastolic dimension in ␤ rabbits compared with control rabbits on echocardiography (Table 1 and Figure 2A ). Hemodynamic data demonstrated an elevation in LV end-diastolic pressure and a decrease in peak negative dp/dt and cardiac output in ␤ rabbits. There was an increase in LV weight in ␤ rabbits at 6 months (Table 1) . Macroscopic examination of the hearts revealed LV hypertrophy, as evidenced by an increase in LV muscle mass, and a decrease in the cavity area ( Figure 2B ). LV muscle mass corrected by the total cross-sectional area was increased in ␤ rabbits. These macroscopic findings were endorsed by microscopic planimetry showing an increase in cross-sectional area per myocyte in ␤ rabbits ( Table 1) .
Histological findings at 3 months included mononuclear cell infiltrates in 3 rabbits each from the ␤ and ␤ϩbiso groups, but not in rabbits from the control group ( Figure 3A) . At 6 months, although cellular infiltrates in the hearts subsided, myocardial hypertrophy with large nuclei, severe disorganizations of the myofibers, and interstitial fibrosis were present in the LV myocardium from ␤ rabbits. ␤ϩbiso rabbits demonstrated this histopathology to a lesser extent ( Figure 3B ).
There was no difference in plasma and LV norepinephrine concentrations among the 3 groups at either 3 or 6 months ( Table 2) . At 3 months, the maximal binding sites of total ␤-ARs were similar in the 3 groups, whereas the percentages of high-affinity binding sites were remarkably decreased in ␤ rabbits. At 6 months, total ␤-ARs tended to decrease, primarily as a function of diminished ␤ 1 receptor density in ␤ rabbits. The percentage of high-affinity binding sites was also decreased ( Table 2) . Isoproterenol-competition curves revealed a loss of guanine nucleotide modulatable binding in ␤ rabbits ( Figure 4A ). With regard to cAMP production, at 3 months, although there was no difference in the basal and Gpp(NH)p-stimulated production in the 3 groups, the isoproterenol-stimulated production was decreased in ␤ rabbits. At 6 months, the basal and Gpp(NH)p-stimulated, as well as isoproterenol-stimulated cAMP production, was decreased in ␤ rabbits (Table 2) . Moreover, the concentrationresponse curves of isoproterenol revealed that the maximal cAMP production was decreased in ␤ rabbits at both 3 and 6 months ( Figure 4B ). These ␤-AR signaling abnormalities in ␤ rabbits were prevented in ␤ϩbiso rabbits. As assessed by immunoblots, at 3 months, there was no difference in protein levels of Gs␣, Gi␣, or GRK2 in the 3 groups, whereas GRK5 protein levels were increased in the membrane fraction from ␤ rabbits. At 6 months, Gi␣ protein levels as well as GRK5 protein levels were increased in the membrane fraction from ␤ rabbits. GRK2 tended to increase in the membrane fraction from ␤ rabbits, although there was no statistical significance. The above findings at 3 and 6 months in ␤ rabbits were prevented in ␤ϩbiso rabbits ( Figures 5 and 6 ).
Discussion
The present study provides 3 new major findings. First, autoimmunity against the second extracellular loop of ␤ 1 -ARs induced early myocardial ␤-AR uncoupling with increased GRK5 expression. Profound desensitization with increased Gi protein expression ensued. Second, the autoimmune process induced cardiac hypertrophy. Third, these changes were prevented by a ␤ 1 -selective antagonist bisoprolol, which has an inverse agonist activity.
Cardiomyopathic Changes Induced by Autoimmunity
By immunizing rabbits with a synthetic peptide corresponding to the second extracellular loop of ␤ 1 -AR, we observed sequential changes in the hearts. As early as 1 month after starting immunization, autoantibodies against the second extracellular loop of ␤ 1 -ARs were persistently detected in both ␤ and ␤ϩbiso rabbits. These autoantibodies exert agonist-like actions on ␤ 1 -ARs. At 3 months, mononuclear cell infiltrates were noted in both ␤ and ␤ϩbiso rabbits, whereas ␤-AR uncoupling with increased GRK5 expression was observed only in the ␤ rabbits. These findings suggest that cellular inflammation with infiltrates does not account for ␤-AR uncoupling and may be a nonspecific immune reaction. Whereas cellular infiltration in the hearts subsided at 6 months, LV hypertrophy with altered cardiac function occurred in the ␤ rabbits. Profound ␤-AR desensitization was noted in the ␤ rabbits and was accompanied by decreased ␤ 1 -AR density and increased Gi protein as well as GRK5 expression, although there was no difference in the plasma norepinephrine concentration in the 3 groups. These results suggest that sustained sympathomimetic actions of the autoantibodies may at least partly account for ␤-AR signaling abnormalities and myocardial hypertrophy, because isoproterenol increases GRK 8 and Gi␣ 6 expression, and induces cardiomyocyte hypertrophy. 7, 9 Matsui et al 22 have demonstrated autoimmune-mediated cardiomyopathy by immunizing rabbits for up to 12 months with the peptide. Biventricular dilation occurred with upregulation of ␤-AR in immunized rabbits, which differs from the findings of the present study. Differences in the immunization period as well as in adjuvant composition or species differences may account for the inconsistent results. Preliminary results from our laboratory have revealed that cavity dilation is not observed in rabbits immunized for up to 12 months. In addition, at 12 months, LV hypertrophy is no longer present and total ␤-AR density was significantly decreased in ␤ rabbits in association with increased plasma norepinephrine concentrations. It is possible that such phenomena may represent an early stage of dilated cardiomyopathy. The different results in the ␤-AR assay could be attributable to differential enrichment of cell membranes due to the filtration methods used in preparation.
Alterations in ␤-Adrenergic Signaling Associated With Autoimmunity
Previous experiments in vitro have shown that incubation of neonatal rat ventricular myocytes with autoantibodies against ␤ 1 -ARs decreases ␤ 1 -AR protein and mRNA expression. 23 This is consistent with the present findings at 6 months, although this finding was preceded by an increase in the GRK5 protein. GRKs have a key role in modulating myocardial adrenergic signaling and cardiac function. 8, 13, 14 GRK5 and GRK2 are enzymes normally expressed in the heart that are rapidly activated after agonist occupancy of receptors. These kinases phosphorylate the receptors, resulting in receptor-G protein uncoupling. Iaccarino et al 8 showed that ␤-AR stimulation with isoproterenol increases expression of GRK2 but not GRK5 in mice. One previous study also showed increased GRK2 but not GRK5 expression in failing rabbit heart after myocardial infarction, 24 whereas another study demonstrated increased GRK5 but not GRK2 expression in a porcine pacing-induced model of heart failure, suggesting that increased GRK5 expression may be one of the earliest changes in heart failure. 25 Ping et al 26 reported that although chronic inhibition of ␤ 1 -AR activation by bisoprolol resulted in downregulation of GRK activity in porcine heart, no change in immunodetectable GRK2 was found, suggesting that reduced GRK5 expression might be responsible for the decreased GRK activity. Thus, it seems possible that selective stimulation of ␤ 1 -ARs by the autoantibodies is partly responsible for the predominant expression of GRK5 in the present study. According to the previous study, 8 GRK2 expression may also increase as the plasma norepinephrine concentration increases in the present model. Actually, GRK2 tended to increase in the membrane fraction from ␤ rabbits at 6 months. Choi et al 14 reported that although pressure-overload cardiac hypertrophy is associated with increased GRK activity, sympathoadrenal activation but not cellular hypertrophy is responsible for the increased GRK activity, which is consistent with our findings at 3 months.
Although relationships between ␤-AR stimulation 6 or heart failure 11, 23, 27 and Gi␣ have been reported, those between autoimmunity and Gi expression have not previously. In the present study, increased Gi protein, coupled with decreased ␤ 1 -AR density or increased GRK5, was responsible for the profound decrease in cAMP production related to altered cardiac function at 6 months. According to a previous report, 28 increased Gi protein, unlike GRK5, may be related to myocardial hypertrophy, although this issue was not clarified in the present study.
Study Limitation and Clinical Implications
We checked cross-reaction of autoantibodies with other cardiac proteins in Western blots using rabbit cardiac ventricular homogenates to confirm the specificity of autoimmunity against ␤ 1 -ARs. We could not detect ␤-ARs clearly, possibly because of their low expression. Therefore, we immunized rabbits together with bisoprolol treatment to confirm that the partial agonist autoantibodies were effecting cardiac toxicity via ␤ 1 -ARs. Cardiomyopathic changes induced by autoimmunity in the present study may involve various factors, including humoral and cellular immunity, and neurohumoral factors such as catecholamines or cytokines. Because there are complex interrelationships among them, it is difficult to specify the exact cause of an individual change. We observed 2 time points for sequential changes in the hearts in addition to bisoprolol treatment and attempted to identify the mechanisms of cardiomyopathic changes seen in the present study. Bisoprolol prevented ␤-AR desensitization and myocardial hypertrophy induced by autoimmunity in the present study. Bisoprolol appears to eliminate toxicity from the partial agonist autoantibodies, rather than toxicity from elevated plasma levels of norepinephrine, because there was no difference in plasma norepinephrine concentration in the 3 groups over the observation period. Based on the fact that the second extracellular domain of ␤-ARs, although not the normal ligand binding site, includes disulfide-bonded cysteine residues and plays an role in ligand affinity regulation and receptor activation, 29 it is speculated that autoantibody binding to the domain may induce the conformational change of the receptor to an active state. 2 On the other hand, although the binding site of ligands such as ␤-adrenergic antagonists resides within the hydrophobic transmembrane domains of the receptor, 29 functional assays demonstrated that bisoprolol has an inverse agonist activity, which is the agonistindependent modulation of receptor activity inducing an inactive conformation with loss of the active state. 21 This suggests that the 2-state model of G protein-coupled receptor activation 21 could explain our results and that inverse agonism rather than direct interaction with autoantibodies may be responsible for the protective effects of bisoprolol in the present study. General hemodynamic effects of ␤ blockers appear insufficient to account for the protective effects of bisoprolol in the present study because the effects on ␤-adrenergic signaling have been apparent at 3 months when there is no difference in any of the hemodynamic parameters among the 3 groups. The elimination of agonist-like actions of the autoantibodies by bisoprolol may also prevent myocardial expression of proinflammatory cytokines induced by chronic ␤-adrenergic stimulation, which are believed to have key roles in the pathophysiology of congestive heart failure, 30 Figure 4 . Assays on ␤-AR and cAMP. A, Isoproterenol-competition curves from 6M rabbits. A decrease in high-affinity binding sites was seen in ␤ rabbits (A-2) compared with control (A-1) and ␤ϩbiso rabbits (A-3). These changes were associated with a loss of guanine nucleotide modulatable binding. In the absence of Gpp(NH)p, both the 1-site model and the 2-site model fitted the curves whereas in the presence of Gpp(NH)p, only the 1-site model fitted the curves in all rabbits. KH and KL indicate dissociation constants for highand low-affinity binding, respectively; Ki, dissociation constant. B, Concentration-response curves of isoproterenol on cAMP production from 3M and 6M rabbits. Isoproterenol-stimulated cAMP production was significantly attenuated in ␤ rabbits at both 3 and 6 months. Moreover, the concentration-response curves differed in the 3 groups of 3M rabbits (PϽ0.05) and of 6M rabbits (PϽ0.001) (repeatedmeasures ANOVA). *PϽ0.05 vs control, †PϽ0.05 vs control and ␤ϩbiso, ‡PϽ0.01 vs control and ␤ϩbiso, **PϽ0.001 vs control and PϽ0.01 vs ␤ϩbiso (Bonferroni post hoc test). Data are meanϮSEM for each group. There was no difference in Gi protein levels in the 3 groups at 3 months (3M), whereas protein levels increased in ␤ rabbits at 6 months (6M). B, Assessment of GRK2 expression at 6 months. There was no difference in GRK2 protein levels in cytosolic and membrane fractions in the 3 groups. C, Assessment of GRK5 expression at 3 months. GRK5 protein levels increased in the membrane fraction from ␤ rabbits, but not in the cytosolic fraction. D, Assessment of GRK5 expression at 6 months. GRK5 protein levels increased in the membrane fraction from ␤ rabbits, but not in the cytosolic fraction. DU indicates densitometric unit. *PϽ0.01 vs control and PϽ0.05 vs ␤ϩbiso, **PϽ0.001 vs control and PϽ0.01 vs ␤ϩbiso (Bonferroni post hoc test). Data are expressed meanϮSEM for each group.
